Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Integrating medical students into the clinical team

Launer’s article highlights how many doctors feel they must choose between medical education and service provision.1 But many […]

January 7, 2026 Uncategorized

Ovarian cancer: Age based blood test thresholds proposed to improve diagnosis

Age based thresholds for blood tests to detect ovarian cancer should be introduced, the National Institute for Health […]

January 7, 2026 Uncategorized

Effects of lifestyle interventions in pregnancy on gestational diabetes: individual participant data and network meta-analysis

AbstractObjectivesTo assess the effects of lifestyle interventions on gestational diabetes, determine whether the effects vary by maternal body […]

January 7, 2026 Uncategorized

Why listening to learners matters in medical education reform

Launer’s concerns about the repeated reorganisations of medical education in the NHS resonate strongly with wider debates about […]

January 7, 2026 Uncategorized

FOLIC ACID tablet [Northwind Health Company, LLC]

Updated Date: Mon, 29 Dec 2025 00:00:00 EST

January 7, 2026 Uncategorized

Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation

Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
p p Read More

First‑in‑class SK ion channel inhibitor enters next stage of clinical development

January 7, 2026 News

A simple drug pair may succeed where liver fibrosis treatments failed

Scientists have found that combining silybin with carvedilol works far better against liver fibrosis than either drug alone. […]

January 6, 2026 Uncategorized

Scientists find a safer way for opioids to relieve pain

Researchers at USF Health have discovered a new way opioid receptors can work that may lead to safer […]

January 6, 2026 Uncategorized

TRIAMTERENE AND HYDROCHLOROTHIAZIDE tablet [Northwind Health Company, LLC]

Updated Date: Mon, 29 Dec 2025 00:00:00 EST

January 6, 2026 Uncategorized

Johnson & Johnson seeks EMA approval for teclistamab–daratumumab combination

Johnson & Johnson seeks EMA approval for teclistamab–daratumumab combination
p p Read More

Company aims to expand treatment options for relapsed or refractory multiple myeloma

January 6, 2026 News

Posts navigation

« Previous

Posts pagination

1 2 … 1,926 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy